Tech Company Financing Transactions

Fenway Pharmaceuticals Funding Round

New Enterprise Associates invested in a $475 thousand venture round for Fenway Pharmaceuticals. The round was announced on 6/30/2008.

Transaction Overview

Announced On
6/30/2008
Transaction Type
Venture Equity
Amount
$475,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
1 Gateway Center 809
Newton, MA 02458
USA
Website
Email Address
Not Recorded
Overview
The company is developing pharmaceutical treatment technologies.
Profile
Fenway Pharmaceuticals LinkedIn Company Profile
Social Media
Fenway Pharmaceuticals Company Twitter Account
Company News
Fenway Pharmaceuticals News
Facebook
Fenway Pharmaceuticals on Facebook
YouTube
Fenway Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Mark Skaletsky
  Mark Skaletsky LinkedIn Profile  Mark Skaletsky Twitter Account  Mark Skaletsky News  Mark Skaletsky on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2008: Xelerated venture capital transaction
Next: 6/30/2008: BMG Seltec venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here come from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary